Wang, James <br/><br/>
Low serum vitamin D occurs commonly among multiple myeloma patients treated with bortezomib and/or thalidomide and is associated with severe neuropathy.  [electronic resource] 

 -  Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer  07 2016 
 - 3105-10 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1433-7339 
<br/><br/><label>Standard No.: </label>10.1007/s00520-016-3126-1  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Bortezomib--adverse effects<br/>Female<br/>Humans<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--complications<br/>Peripheral Nervous System Diseases--chemically induced<br/>Thalidomide--adverse effects<br/>Vitamin D--blood